Radiologists are more likely to follow Medicare policy initiatives regarding CT double-scans than are nonradiologists.
Medicare policy initiatives regarding the use of thoracic and abdominal CT double-scans reduced the rate among radiologists, but not as much among nonradiologists, according to a study in the Journal of the American College of Radiology.
Researchers from the University of Colorado in Aurora, the University of Texas Health Science Center at San Antonio, and Emory University School of Medicine in Atlanta, GA, sought to examine trends in the relative utilization of double-scan CT before and after 2006 legislation mandating relevant Medicare reporting initiatives.
Data were obtained from the Medicare Physician Supplier Procedure Summary Master Files from 2001 through 2012 to identify claims for thoracic and abdominal CT examinations. The researchers looked for the use of double-scan CT between radiologists and nonradiologists.
The results showed that use of both CT examinations by radiologists were decreasing already in 2001 and continued to do so following the CMS mandate, while this was not the case with nonradiologists.
Change from 2001 to 2006
Change from 2006 to 2012
“Double-scan rates were significantly lower for radiologists than nonradiologists for all years for abdominal CT and for all years after 2006 legislation for thoracic CT,” the authors wrote.
The researchers concluded that CMS initiatives designed to reduce costs and radiation exposure to patients influenced radiologists at greater rates than nonradiologists.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.